Clinical trialNCT03485911CompletedPhase 3Interventional

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

SponsorBioCryst PharmaceuticalsEnrollment121HAEHereditary Angioedema

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bruce Zuraw, MD
UC San Diego School of Medicine, US HAE Angioedema Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Study Center
Vienna, Austria

Canada

Study Center
Ottawa, Ontario, Canada
Study Center
Toronto, Ontario, Canada
Study Center
Québec, Canada

Czechia

Study Center
Brno, Czechia
Study Center
Pilsen, Czechia

France

Study Center
Grenoble, France
Study Center
Paris, France

Germany

Study Center
Berlin, Germany
Study Center
Frankfurt, Germany

Hungary

Study Center
Budapest, Hungary

North Macedonia

Study Center
Skopje, North Macedonia

Romania

Study Center
Sângeorgiu de Mureș, Jud. Mureș, Romania

Spain

Study Center
Barcelona, Spain
Study Center
Madrid, Spain
Study Center
Seville, Spain

United Kingdom

Study Center
Cambridge, United Kingdom
Study Center
Frimley, United Kingdom
Study Center
London, United Kingdom
Study Center
Plymouth, United Kingdom

United States

Study Center
Birmingham, Alabama, United States
Study Center
Scottsdale, Arizona, United States
Study Center
Little Rock, Arkansas, United States
Study Center
San Diego, California, United States
Study Center
Santa Monica, California, United States
Study Center
Walnut Creek, California, United States
Study Center
Colorado Springs, Colorado, United States
Study Center
Tampa, Florida, United States
Study Center
Chevy Chase, Maryland, United States
Study Center
Boston, Massachusetts, United States
Study Center
Ann Arbor, Michigan, United States
Study Center
Plymouth, Minnesota, United States
Study Center
St Louis, Missouri, United States
Study Center
Belleville, New Jersey, United States
Study Center
Fair Lawn, New Jersey, United States
Study Center
Piscataway, New Jersey, United States
Study Center
New York, New York, United States
Study Site
Charlotte, North Carolina, United States
Study Center
Durham, North Carolina, United States
Study Center
Cincinnati, Ohio, United States

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Feb 2018
Primary completion: 10 Apr 2019
Completion: 6 Apr 2022
Last update posted: 26 Jun 2023
Registered enrollment: 121
Registry id: NCT03485911

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.